ECO Animal Health Group (LON:EAH) Shares Pass Above Fifty Day Moving Average - Should You Sell?

Key Points

• The stock price of ECO Animal Health Group has recently crossed above its 50-day moving average of GBX 64.13, reaching a high of GBX 80 during trading.
• Shore Capital has reaffirmed a "buy" rating for the company, setting a price target of GBX 150 ($2.00) on its shares.
• Insider David Hallas purchased 29,897 shares at an average cost of GBX 67, reflecting significant insider confidence as insiders currently own 21.65% of the stock.

ECO Animal Health Group plc (LON:EAH - Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 64.13 ($0.85) and traded as high as GBX 80 ($1.06). ECO Animal Health Group shares last traded at GBX 75.22 ($0.99), with a volume of 54,143 shares trading hands.

Analysts Set New Price Targets

Separately, Shore Capital reaffirmed a "buy" rating and issued a GBX 150 ($1.98) price objective on shares of ECO Animal Health Group in a research report on Monday, July 14th.

ECO Animal Health Group Stock Up 0.7%

The firm's 50-day simple moving average is GBX 65.03 and its 200 day simple moving average is GBX 61.39. The company has a debt-to-equity ratio of 4.81, a quick ratio of 2.14 and a current ratio of 2.96. The stock has a market capitalization of £51.50 million, a P/E ratio of 49.13 and a beta of -0.05.

ECO Animal Health Group (LON:EAH - Get Free Report) last issued its quarterly earnings results on Monday, July 14th. The company reported GBX 2.49 ($0.03) EPS for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

Insider Buying and Selling

In other ECO Animal Health Group news, insider David Hallas purchased 29,897 shares of ECO Animal Health Group stock in a transaction that occurred on Tuesday, July 15th. The stock was acquired at an average price of GBX 67 ($0.89) per share, for a total transaction of £20,030.99 ($26,461.02). Insiders own 21.65% of the company's stock.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.